Tryptamine compounds, and methods of cerebrovascular treatment t

Details Tryptamine compounds, and methods of cerebrovascular treatment t Tryptamine compounds, and methods of cerebrovascular treatment t

1986-12-23

1990-12-25

Springer, David B.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514212, 514339, 514419, 540524, 546201, 548492, 548504, C07D20916, C07D20918, A61K 3140, A61K 31395

Patent

active

049803689

ABSTRACT:
A compound of formula (I) or a pharmaceutically acceptable salt thereof: ##STR1## wherein: R.sub.1 is hydrogen, C.sub.1-6 alkyl, C.sub.1-6 alkoxy or halogen;

REFERENCES:
patent: 3042685 (1962-07-01), Allais et al.
patent: 3217029 (1965-11-01), Shavel et al.
patent: 3296072 (1967-01-01), Szmuszkovicz
patent: 3639414 (1972-02-01), Archer
patent: 3910953 (1975-10-01), Szantay et al.

Affiliated with

Also associated with

Rating

Tryptamine compounds, and methods of cerebrovascular treatment t does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tryptamine compounds, and methods of cerebrovascular treatment t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tryptamine compounds, and methods of cerebrovascular treatment t will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1163044